| |
Hemangioblastoma |
|
The Key Features |
-
Association with VHL
syndrome;
-
Locations:
posterior cranial
fossa » spinal cord;
-
Capillary vasculature,
foamy stromal cells (true tumor cell), mast cells;
-
Stromal cells:
inhibin+, NSE+, S100+, EGFR+; EMA−, CK−.
|
|
|
CLINICAL FEATURES |
| |
-
A benign or grade I tumor
in
the WHO Classification. Accounts for approximately 1-2% of
intracranial tumors.
- Locations: mostly
in the cerebellum, especially the posterior cranial fossa, and
is the most common primary adult intraaxial posterior fossa
tumor. Cerebellar
hemangioblastomas are frequently referred to as Lindau tumors.
The second most common location is the spinal cord,
but only accounts for 1-2% of
hemangioblastomas, and they are almost exclusively
intramedullary.
-
Male-to-female
ratio approximately 2:1
-
Age: usually
between the third and fifth decades.
Rarely
affect children.
-
Most cases
occur sporadically, but 25% associate with the von
Hippel-Lindau syndrome
Features for VHL association: younger age
(3rd-4th
decade vs 5th-6th decade);
multiple
tumors; and extra cranial.
In up to 20% of cases, the cells have endocrine function and
produce erythropoetin that causes polycythemia.
|
|
GROSS FINDINGS |
| |
- The cerebellar
tumor often occurs as a cystic lesion with a mural mass usually
abut the leptomeninges . The mural mass represents the real
tumor. The spinal tumor typically intramedullary, discrete and
usually in contact with the leptomeninges posterior.
-
The cut surface of the tumor are
usually vascular/spongy and red-brown to yellow,
due
to their dense vasculature and high lipid content.
They may include a cyst that contains a clear fluid, but solid
tumors are as common as cystic ones. The tumor usually grows
inside the parenchyma of the cerebellum, brain stem, or spinal
cord; it is attached to the pia mater.
|
|
MICROSCOPIC FINDINGS |
| |
- Architecture:
The tumor is normally well-demarcated. Variable cellularity of
highly cellular areas alternating with paucicellular regions
composed of predominantly dilated vessels and cysts.
- Cytology; consists of two
distinct cellular components. 1). vasculature,
consists of
large feeding and draining vessels and innumerable intervening
capillaries. The capillaries are
composed of small, perivascular,
endothelial cells that have dark compact nuclei and sparse
cytoplasm; 2).
Stromal cells (the
actual neoplastic cells),
contain multiple vacuoles and granular foamy cytoplasm rich in
lipids. These stromal cells may show some nuclear pleomorphism,
but mitotic figures rarely are seen. The nuclei of stromal cells
are mainly medium in size, round, or reniform with scattered
large hyperchromasia. The exact histogenetic origin of stromal
cells is unknown.
- Mast cells are commonly seen in
the tumor that can be highlight with roluidine blue or Giemsa
stain.
|
|
SUBTYPES |
| |
- Cellular
variant: aggregation of stromal cells in large cohesive
nests and lobules with an epithelioid presentation.
Higher recurrence.
-
Reticular variant: more common.
composed of predominantly of small nests and individual cells,
especially rich in reticulin.
|
|
DIFFERENTIAL DIAGNOSES |
| |
-
Metastatic
renal cell carcinoma: similar histologic appearance and
similar incidence in patients with von Hippel-Lindau syndrome.
On HE stained sections, renal cell carcinoma can have necrosis,
mitosis and large nucleoli, features almost always absent on
hemangioblastoma. Renal cell carcinoma is also immunoreactive
for cytokeratin, CD10, and EMA, while hemangioblastoma is
positive for inhibin, but negative for cytokeratin,
CD10, and EMA.
-
Other
neoplasms with clear cell features include clear cell
epdneymomas, clear cell meningioma with prominent vascularity,
central liponeurocytoma of the cerebellum, and other metastatic
clear cell neoplasms. Ependymomas are strongly are strongly
immunoreactive for GFAP. Clear cell meningioma usually contains
areas with features of classic meningothelial pattern and they
are also immunoreactive for EMA. Central liponeurocytoma
contains adipocytes and the neurocytoma cells are
immunoreactive for synaptophysin. Metastatic carcinoma are
immunoreactive for cytokeratin and, often, EMA.
-
Capillary hemangioma:
no vacuolated interstitial cells.
|
|
IMMUNOHISTOCHEMISTRY AND SPECIAL STAINS |
| |
-
The stromal cells stain strongly for
S100,
NSE, vimentin,
EGFR
and PDGF-alpha and inhibin, and they are typically negative for
EMA, cytokeratin, neurofilament, and synaptophysin. In a small
number of cases, the stromal cells express glial fibrillary
acidic protein (GFAP).
-
The admixed capillaries stain for with typical endothelial
markers, CD31, CD34 and Factor-VIII.
|
|
ELECTRON MICROSCOPIC FINDINGS |
| |
- Stromal cells: intracytoplasmic
lipid droplets, microfilaments and SER/RER;
- Endothelial cells:
Weibel-Palade bodies.
|
|
CYTOGENETIC STUDIES |
| |
- VHL gene mutation in VHL
syndrome associated cases.
|
|
TREATMENT AND PROGNOSIS |
| |
|
|
REFERENCES |
| |
- AFIP, tumor of the central
nervous system, series 4;
- Rosai and Ackerman's Surgical Pathology, 9th edition;
- http://moon.ouhsc.edu/kfung/JTY1/Com04/Com407-1-Diss.htm
-
http://www.emedicine.com/med/topic2991.htm
|